TFR2 and hepatocellular carcinoma: EZH2 is highly expressed in hepatocellular carcinoma (HCC) and can regulate the levels of histone H3K27me3 in the promoter region of TFR2, maintaining iron homeostasis in HCC and inhibiting ferroptosis [41].